
                                                                    EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with the Annual Report of Advanced  Biotherapy,  Inc. (the
"Company")  on Form 10-KSB for the year ended  December 31, 2004,  as filed with
the  Securities  and  Exchange  Commission  on the date  hereof  (the  "Periodic
Report"), I, Edmond F. Buccellato,  President and Chief Executive Officer of the
Company,  certify,  pursuant to 18 U.S.C.  Section 1350, as adopted  pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

      1.    the Periodic Report fully complies with the  requirements of Section
            13(a) or 15(d) of the Securities Exchange Act of 1934; and

      2.    the information contained in the Periodic Report fairly presents, in
            all  material  respects,  the  financial  condition  and  results of
            operations of the Company.

Dated:     April 13, 2005                /s/Edmond F. Buccellato
                                         ---------------------------------------
                                         Edmond F. Buccellato, President and
                                         Chief Executive Officer

